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1. Introduction 2. Materials 
The initial discovery that TYMV*-RNA had a tRNA- 
like structure able to be recognized by several en- 
zymes that utilize tRNA as substrate [ 1-4] has been 
complemented by the recent description of other 
plant viral RNA having similar properties. RNA from 
bromegrass mosaic virus incorporates tyrosine [5] 
while TMV-RNA is aminoacylated byhistidine in the 
presence of yeast histidyl-tRNA synthetase [6, 7]. It 
has also been reported that TMV after being cleaved 
by plant endonuclease can accept methionine and 
serine [8]. 
The present report deals with some properties of 
the histidine incorporation i to TMV-RNA. RNA 
from four strains of TMV have been used and impor- 
tant differences of the extent of aminoacylation were 
found. RNAase T 1 treatment has shown that histidine 
is acylated to a tetranucleotide compatible with the 
known sequence of TMV-RNA at its 3' end. The dif- 
ference between the aminoacylation f the four 
strains of TMV-RNA was studied in some detail and it 
was found that this difference may be related to a dif- 
ference in structure at the 3' end. 
* Abbreviations: TMV = tobacco mosaic virus; TYMV = tur- 
nip yellow mosaic virus; DMSO = dimethyl sulfoxide; 
TCA = trichloroaeetic a id; PPO = 2,5-diphenyloxazole; 
POPOP = 1,4-bis-2-(4-methyl-5-phenyloxazolyl) benzene. 
TMV-RNA of the following strains: Vulgare, U 2, 
dahlmensis and HRG were a kind gift of 
Dr. K.W. Mundry from Ttibingen; TMV was a gift of 
Dr. Vincent Santilli from the Faculty of Sciences, 
Santiago, Chile; total yeast RNA was purchased at 
Nutritional Biochemical Co.; [14C] histidine (43 
mCi/mmole) was obtained from the Commissariat 
a l'Energie Atomique, Saclay, France; RNAase T 1 
was obtained from Worthington and DMSO from 
Sigma Chemical Co. 
3. Methods 
3.1. Histidine incorporation onto TMV-RNA 
In a total volume of 0.2 ml, the incubation mix- 
ture contained 10/1moles of Tris-HC1 pH 7.5, 
2/.tmoles of MgC12, 0.4/amoles of/3-mercaptoethanol, 
1/lmol of ATP, 2/aCi of [14C]histidine, 20-50/ag of 
HRS and 50 pmoles of TMV-RNA, unless otherwise 
stated. The incubation was carried out at 37°C for 
different lengths of time. The reaction was stopped 
by addition of 2 ml of cold bovine serum albumin 
(50 mg/£) and 0.1 ml of 50% TCA. The precipitate 
was filtered through a Whatman glass fiber filter GF/A, 
washed with 50 ml of cold 5% TCA containing cold 
histidine, dried and counted in a toluene-PPO- 
POPOP scintillation mixture. 
3.2. Partial purification o f  yeast HRS 
Fifty grams of yeast (a kind gift of La Tdguefia 
Ltd. Santiago, Chile) were suspended in half a volume 
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of a buffer containing 0.05 M Tris-HC1, pH 7.5, 
I 00  
0.01 M MgC12 and 0.001 M j3-mercaptoethanol, t  
form a viscous lurry. This suspension was passed 
through a French press homogenizer at9000 psi. The 
broken cells were centrifuged at 10 000g for 30' 
and the supernatant centrifuged in a Spinco model L 
ultracentrifuge for 2 hr at 105 000 g. The high speed ~ 50 
u 
supernatant was adsorbed to a DEAE-cellulose column 
equilibrated with the buffer described above. Proteins 
were eluted using a KC1 gradient (0-0.4 M, 250 ml of 
each) prepared in the same buffer. Fractions of 5 ml 
were collected and the HRS activity was detected by 
[14C]histidine incorporation i to total yeast RNA 
(4 nmoles per assay). The tubes showing HRS activity zoo 
were pooled, precipitated to 80% saturation with 
(NH4)2SO4, dissolved and dialyzed against buffer A 
and kept at -20°C in 30% glycerol. E o ,  
u 
3.3. DEAE-cellulose chromatography ofthe RNAase 
T 1 digest of TMV-RNA charged with [14C]histi- 
dine 
The method was identical to the one described by 
Yot et al. for RNAase T 1 digest of [14C]valyl-TYMV- 
RNA [21. 
3.4. Preparation of TMV protein 
Four ml of glacial acetic acid were added to 2 ml 
of ice cold purified TMV at 10 mg/ml in 0.05 M phos- 
phate buffer, pH 7.0. After 1 hr in ice with occasional 
stirring, the viral suspension was centrifuged for 15 
rain at 15 000 g. The supernatant is dialyzed extensive- 
ly against distilled water until the solution becomes 
very milky. This suspension is centrifuged at 105 000g 
for 1 hr in the cold. The precipitate is suspended in
I ml of water. The protein is dissolved by adjusting the 
solution at pH 8 with KOH under constant stirring. 
We have assumed that 1 mg of TMV protein gives an 
absorbance at280 nm of 0.8. 
I 00  
A( ~-t yrosinl 
CACCA- voline 
J 
I 
UZ 
. . . - _ - 
Vulgate 
L . . . . . . . . . . . . . . . . . . . . . . . .  n flflnl~ 
50 I00 
Froct ion N e 
Fig. 1. DEAE-cellulose chromatography of an RNAase T 1 di- 
gest of histidyl-RNA TMV. TMV-RNA acylated with [~4C] his- 
tidine (lmg, 25 000 cpm) was digested with RNAase T] as 
described previously [2]. The digestion product was put in a 
DEAE-cellulose column (0.8 × 14 cm) equilibrated with 7 M 
urea in 0.05 M ammonium acetate, pH 5.5, and then eluted 
with an ammonium acetate gradient between 0.05 and 0.6 M. 
One ml fractions were collected and then radioactivity 
counted. 
Incubation was carried out for different lengths of 
time, at 37°C. The reaction was stopped and the radio- 
active material washed and counted as described for 
the HRS assay. 
3.5. Assay for the deacylation ofl histidyl-TMV-RNA 
In a final volume of 0.2 ml the incubation mixture 
contained 5ttmoles of sodium cacodylate buffer pH 
7.0, I/amol of AMP, 1 #mol of sodium pyrophosphate, 
1/amol histidine, 10/~moles of MgC12, 1 #mol of 13. 
mercaptoethanol, 50-100 #g of HRS, 100-150 #g of 
14C-labeled TMV-RNA or 20-30 #g tRNA sterified 
with [ 14C]histidine. 
4. Results and discussion 
4.1. TMV-RNA aminoacylation studies 
As shown previously, TMV-RNA is specifically 
aminoacylated with histidine but not with any other 
of the naturally occurring amino acids [7]. The 3' ter- 
minal sequence of TMV-RNA has been determined to 
be GCCCA-OH [ I 1]. This implies that aminoacylation 
followed by RNAase T! digestion should yield an 
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Fig. 2. Enzymatic deacylation of histidyl TMV-RNA. Incuba- 
tion was carried out as described under Methods. 
aminoacyl-tetranucleotide with a CCCA composition. 
Fig. 1 gives the results obtained in such an experiment. 
DEAE-cellulose chromatography of the digest yields a 
radioactive peak that co-elutes with ACCA-tyrosyl ob- 
tained by a similar treatment of yeast tyrosyl-tRNA. 
The results obtained with the U 2 and vulgare strains 
were identical. As shown previously [7], DMSO and 
formaldehyde treatment of the acylated TMV-RNA 
showed that the amino acid was still bound to the 24 S 
viral RNA, thus eliminating the possibility that the 
acceptor capacity was due to contaminating tRNA. 
Enzymatic deacylation of histidyl-TMV RNA was 
studied as shown in fig. 2. Yeast histidyl-tRNA synthe- 
tase causes deacylation of the viral RNA and requires 
the presence of pyrophosphate and AMP. The reaction, 
under comparable conditions, seems to go significant- 
ly more slowly than the deacylation of yeast histidyl- 
Table 1 
Effect of TMV coat protein on the histidine acylation of 
TMV-RNA (U2) and yeast RNA. 
Additions pmoles of Histidine incorporated 
None (TMV RNA) 17 
Coat protein (40 tag) 16 
Coat protein (80 #g) 18 
None (yeast RNA) 89 
Coat protein (80 #g) 91 
None (TMV) < 1 
Table 2 
Histidine incorporation i to different strains of TMV-RNA. 
TMVstrain pmoles Histidine bound per mol 
of TMV-RNA 
U 2 0.40 
Vulgare 0.37 
Dahlmensis 0.09 
HRG 0.13 
The incubation was performed for 15 min in the conditions 
described in the text. 
tRNA. Similar experiments performed with valyl- 
TYMV RNA gave an even lower rate of enzymatic 
deacylation as compared to valyl-tRNA [ 10]. 
The effect of the coat protein on the aminoacyla- 
tion of TMV RNA was tested as shown in table 1. As 
can be observed, the whole virus particle cannot be 
aminoacylated. However, the addition of coat protein 
does not inhibit the acceptor capacity of  TMV RNA 
or of yeast tRNA. The reconstitution of viral particles 
by addition of RNA and coat protein can be attained 
in vitro, but it requires prolonged incubation under 
special conditions [12]. It has been shown that assem- 
bly starts by addition of coat protein to regions of 
RNA. 
4.2. Difference in histidine aeceptor capacity of RNA 
of TMV strains 
Differences in the histidine acceptor capacities of 
RNA obtained from different strains of TMV have 
been examined. In table 2 it can be observed that the 
4 strains studied can be classified into two groups, 
RNA's from vulgare and U 2 have an acceptor capacity 
of approximately 0.4 moles of amino acid per mole 
of RNA. The other two strains, dahlmensis and HRG 
are poorer histidine acceptors with only a 0.1 value. 
This difference is apparently not due to a slower 
reaction occurring with the RNA's showing low 
acceptor capacities. This is inferred from the results 
shown in fig. 3, in which the time course of  amino- 
acylation of U 2 and HRG was followed. It is clear 
that the initial velocities of histidine incorporation 
were quite similar while the plateaux of labelling dif- 
fered considerably. 
The experiment shown in fig. 4, however, indicates 
that the lower capacity of the RNA's from some 
strains is probably due to differences in the folding of 
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Fig. 3. Kinetics of histidine incorporation i to two strains of 
TMV-RNA. The incubation was performed as described under 
Methods: TMV-RNA U2 (e - -e - -e ) ;  TMV-RNA HRG 
(o--o--o). 
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Fig. 5. Effect of DMSO on the histidine incorporation i to 
TMV-RNA. TMV-RNA of the dahlmensis strain was incubated 
with different amounts of DMSO as described under Methods. 
the polynucleotide structure. Pre-heating the HRG 
strain RNA to 80°C for 10 min apparently increases 
the amount of RNA molecules capable of accepting 
histidine to a degree comparable or higher to that of 
the U 2 and vulgare strains. An attempt to show the 
same effect by using a denaturing agent such as DMSO 
failed to increase the accepter capacity. In fact, fig. 5 
shows that this compound causes ignificant inhibition 
of TMV acylation. DMSO has been shown to increase 
the aminoacylation f tRNA when heterologous 
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Fig. 4. Effect of temperature onthe histidine incorporation 
into TMV-RNA. TMV-RNA of the HRG strain was preincu- 
bated at 80°C for 10 min in the presence of the incubation 
mixture described in the text with the exception of the amino- 
acyl-tRNA ligases. The mixture was brought o 37°C, the 
ligases added and the incubation carried out for different 
lengths of time (e - -e - -  e) Control; (o - -o - -o )  heated. 
ligases are used [9]. 
5. Conclusions 
The 3' end of TMV RNA possesses a tRNA-like 
structure that can be specifically acylated with histi- 
dine by the yeast histidyl-tRNA synthetase. 
This enzyme can also catalyze the reaction of 
deacylation of histidyl-RNA(TMV) in the presence of 
AMP and PPi. In this reaction the kinetics of the en- 
zyme seem to be slower than for histidyl-tRNA (yeast). 
Various strains of TMV RNA differ in the initial 
accepter capacity but apparently this is due to the 
folding of these RNA molecules because pre-heating 
at 80°C makes the unreactive RNA species accept 0.6 
moles of histidine/mole of RNA. 
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